Register entry
- Registered sites
- 0
- Active NDC listings
- 5
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
55 active NDC listings: 5 human prescription drug. By marketing category: ANDA 4, NDA AUTHORIZED GENERIC 1.
| Dosage form | NDCs |
|---|---|
| capsule | 4 |
| tablet, delayed release | 1 |
| Route | NDCs |
|---|---|
| oral | 5 |
| Labeller name on the listing | NDCs |
|---|---|
| analog pharma | 5 |
Catalogue
Marketed products
5| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Doxylamine succinate and pyridoxine hydrochloride | Doxylamine succinate and pyridoxine hydrochloride | tablet, delayed release, oral | 70505-100NDA AUTHORIZED GENERIC |
| Nitisinone | Nitisinone | capsule, oral | 70505-202ANDA |
| Nitisinone | Nitisinone | capsule, oral | 70505-205ANDA |
| Nitisinone | Nitisinone | capsule, oral | 70505-210ANDA |
| Nitisinone | Nitisinone | capsule, oral | 70505-220ANDA |
Compare
Other companies listing nitisinone
- Cohance Lifesciences Limited6 sites · 74 NDC
- Par Health USA, LLC5 sites · 211 NDC
- Anthem Biosciences Limited3 sites · 7 NDC
- Bryant Ranch Prepack1 site · 4,357 NDC
- NURAY CHEMICALS PRIVATE LIMITED1 site · 105 NDC
- Bachem AG1 site · 23 NDC
- Amino Chemicals Ltd.1 site · 9 NDC
- Cycle Pharmaceuticals Ltd-Uk0 sites · 19 NDC
- Swedish Orphan Biovitrum AB (publ)0 sites · 15 NDC
- Eton Pharmaceuticals, Inc.0 sites · 14 NDC
Enquiry
Common questions
- Is Analog Pharma FDA approved?
- Analog Pharma holds no registered establishment of its own; 5 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Analog Pharma make?
- 5 products are listed under Analog Pharma in the openFDA NDC Directory, most often as capsule; tablet, delayed release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.